Clinical ink is expanding its patient engagement suite with the inclusion of the SPUR™ behavioral diagnostic tool created by Observia.
Clinical ink is setting a new industry benchmark in advancing study build timelines. Harnessing the power of the latest eCOA technology, Clinical ink can now reduce study build timelines to as little as 10 days.
Clinical ink, a global life science technology company, announces the appointment of Jeff Bock, Vice President of Data Management and Tom Haag, Vice President of Data Quality Control.
Clinical ink announced the appointment of Andrew Kraus as Chief Technology Officer who will lead the development of the company’s expanding technology portfolio to support clinical trials.
Clinical ink is delighted to announce its partnership with Teckro, a trailblazer in site user engagement and clinical trial technology solutions.
Clinical ink announces the publication of “Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study” in npj Parkinson’s Disease.
Clinical ink now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution.
Clinical ink announces its strategic partnership with Mural Health, a next-generation participant management platform.